UBS Group AG

Position in FTXH — First Trust Nasdaq Pharmaceuticals ETF

CIK 1610520 ZURICH, V8

Back to FTXH Full portfolio

All Filings in FTXH

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31 FTXH	$20,168	587	+288.7%	Shares	Defined	2026-05-05
2025-12-31 FTXH	$4,973	151	-96.9%	Shares	Defined	2026-01-29
2025-09-30 FTXH	$137,195	4,810	+20.4%	Shares	Defined	2025-11-13
2025-06-30 FTXH	$102,413	3,996	+37.5%	Shares	Defined	2025-08-14
2025-03-31 FTXH	$79,885	2,906	+93.2%	Shares	Defined	2025-05-13
2024-12-31 FTXH	$40,559	1,504	+5086.2%	Shares	Sole	2025-02-14
2024-06-30 FTXH	$790	29	-98.3%	Shares	Sole	2024-08-14
2023-12-31 FTXH	$46,416	1,744	-59.1%	Shares	Sole	2024-02-09
2023-06-30 FTXH	$111,582	4,261	+142.0%	Shares	Sole	2023-08-11
2023-03-31 FTXH	$45,958	1,761	-15.3%	Shares	Sole	2023-05-12
2022-12-31 FTXH	$57,001	2,078	+386.7%	Shares	Sole	2023-02-08
2022-09-30 FTXH	$10,265	427	-48.4%	Shares	Sole	2022-11-10
2022-03-31 FTXH	$22,032	828	+127.5%	Shares	Sole	2022-05-16
2021-12-31 FTXH	$9,849	364	-62.0%	Shares	Sole	2022-02-14
2021-09-30 FTXH	$24,705	958	+7.5%	Shares	Sole	2021-11-15
2021-06-30 FTXH	$23,059	891	-60.6%	Shares	Sole	2021-08-13
2021-03-31 FTXH	$57,867	2,264	+20481.8%	Shares	Sole	2021-05-12
2020-12-31 FTXH	$283	11	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.